Cargando…
Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits
BACKGROUND: Atherosclerotic cardiovascular disease is one of the major diseases that seriously impacts human health. Combined drug therapy may be efficacious in delaying the occurrence of cardiovascular events. AIM: The current study was designed to investigate whether combined use of probucol (an a...
Autores principales: | Wang, Yanli, Bai, Liang, Lin, Yan, Chen, Yulong, Guan, Hua, Zhu, Ninghong, Li, Yafeng, Gao, Shoucui, Sun, Lijing, Zhao, Sihai, Fan, Jianglin, Liu, Enqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517357/ https://www.ncbi.nlm.nih.gov/pubmed/26220196 http://dx.doi.org/10.1186/s12944-015-0083-5 |
Ejemplares similares
-
Temporal and Quantitative Analysis of Atherosclerotic Lesions in Diet-Induced Hypercholesterolemic Rabbits
por: Yu, Qi, et al.
Publicado: (2012) -
Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014) -
Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits
por: Niimi, Manabu, et al.
Publicado: (2013) -
Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits
por: Zhao, Sihai, et al.
Publicado: (2015) -
Genomic and Transcriptomic Analysis of Hypercholesterolemic Rabbits: Progress and Perspectives
por: Fan, Jianglin, et al.
Publicado: (2018)